Your session is about to expire
← Back to Search
JSP191 for MDS/AML
Study Summary
This trial is testing a new antibody conditioning regimen to see if it is safe and tolerable for people with Myelodysplastic Syndrome or Acute Myeloid Leukemia who are undergoing allogenic blood stem cell transplantation.
- Myelodysplastic Syndrome
- Acute Myeloid Leukemia
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Rewritten Criteria:
1. You currently have an infection that is not being treated or managed properly.
2. You are currently receiving an experimental medication for another study.
3. You have an active cancer that is not a blood cancer.
4. You have had a bone marrow transplant using cells from another person.
- Group 1: Blood Stem Cell Transplant w/ anti-CD117 conditioning
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has the Humanized anti-CD117 Monoclonal Antibody (JSP191) been granted regulatory authorization by the FDA?
"The safety of Humanized Anti-CD117 Monoclonal Antibody (JSP191) is rated as a 1 due to the preliminary nature of Phase 1 trials, in which there is little data available on efficacy and safety."
What is the geographical spread of this trial's implementation?
"At the moment, 6 clinical sites are running this trial. Apart from Portland, Stanford and Salt Lake City there is another trio of locations available to choose from. It's important that participants select a nearby site in order to minimize their traveling duties should they participate."
What is the enrollment rate of this research project?
"Affirmative. According to the information hosted on clinicaltrials.gov, this study is currently recruiting participants after its initial posting date of July 8th 2020 and subsequent revision on June 8th 2021. The trial hopes to register 40 patients from 6 different sites."
Are there any available slots in this research project?
"Affirmative. As per the information on clinicaltrials.gov, this clinical trial is actively searching for patients to enroll in their research; it was initially posted on July 8th 2020 and edited most recently on June 8th 2021. Participants are needed from 6 distinct medical sites with a total of 40 required overall."
Share this study with friends
Copy Link
Messenger